Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Auchenflower
Clinical trial register · Australia

Clinical Trials in Auchenflower, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 54 Darlinghurst 29 Nedlands 29 Heidelberg 27 Clayton 26
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca8 Amgen7 Pfizer5 Novartis Pharmaceuticals4 Queensland Centre for Gynaecological Cancer3 Clear sponsor filter
Site location
Melbourne54 Darlinghurst29 Nedlands29 Heidelberg27 Clayton26
All 103 locations
Target enrolment
to

Trials with a site in Auchenflower

8 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
DrugsTorvutatug samrotecan·Bevacizumab
AstraZeneca
Phase 3
600
Auchenflower, Blacktown, Clayton, Liverpool
2026-09-24
Recruiting
AstraZeneca
Phase 3
950
Auchenflower, Benowa, Hobart, Kingswood, Nedlands, Port Macquarie, Randwick, Richmond
2026-09-16
Recruiting
AstraZeneca
Phase 3
915
Auchenflower, Ballarat, Clayton, Darlinghurst, Elizabeth Vale, South Brisbane, St Albans
2026-07-16
Recruiting
AstraZeneca
Phase 3
1,100
Adelaide, Auchenflower, Campbelltown, Camperdown, Clayton, Cudgen, Garran, Gosford
2025-12-29
Active, closed
AstraZeneca
Phase 3
506
Adelaide, Auchenflower, Clayton, Heidelberg, St Leonards, Subiaco
2021-06-22
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
477
Auchenflower, Blacktown, Camperdown, Heidelberg, Melbourne, Nedlands
2020-08-18
Active, closed
AstraZeneca
Phase 3
1,018
Auchenflower, Box Hill, Brisbane, Kogarah, Orange, Parkville, Westmead, Wollongong
2018-05-14
Active, closed
AstraZeneca
Phase 3
1,837
Adelaide, Auchenflower, Concord, Douglas, Gosford, Hobart, Malvern, Melbourne
2014-04-22
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/auchenflower

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Auchenflower that also match the filters currently applied.

How many clinical trials are recruiting in Auchenflower?

4 of the 8 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Auchenflower), 8 studies
PhaseStudiesRecruitingShare
Phase 37487.5%
Phase 21012.5%

Most active sponsors

Lead sponsors with the most studies (Auchenflower)
Lead sponsorStudiesRecruiting
AstraZeneca84
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.